Endodontic therapy and incident cardiovascular disease: The Atherosclerosis Risk in Communities (ARIC) study.

cardiovascular diseases coronary disease endodontic endodontic treatment heart failure infection stroke venous thromboembolism

Journal

Journal of public health dentistry
ISSN: 1752-7325
Titre abrégé: J Public Health Dent
Pays: United States
ID NLM: 0014207

Informations de publication

Date de publication:
01 2020
Historique:
received: 06 02 2019
revised: 17 10 2019
accepted: 13 11 2019
pubmed: 23 1 2020
medline: 31 7 2020
entrez: 23 1 2020
Statut: ppublish

Résumé

Previous studies on a potential association between endodontic infection (EI) and cardiovascular disease (CVD) produced mixed results. Endodontic treatment (ET) may also be linked to cardiovascular risk, as a marker for prior chronic dental infection and subclinical EI in other teeth. We tested the hypothesis that ET is associated with elevated risk of coronary heart disease (CHD), ischemic stroke (IS), heart failure (HF), or venous thromboembolism (VTE). ARIC participants who completed the dental ancillary study exam 4 (1996-1998; n = 6,638) were included in the analyses. Participants were followed through 2013 for CHD, stroke, and HF and 2011 for VTE. Cox-proportional hazards regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for CHD, IS, HF, and VTE across ET classifications adjusting for age, sex, race/center, education, income, smoking, alcohol consumption, BMI, statin use, family history of CHD, physical activity, diet quality, insurance status, last dental visit, dental visit frequency, having a current dentist, and tooth loss due to gum disease. Among participants, 21.0% reported a single ET, while 28.5% reported multiple ETs. Over a median of 15.8 years of follow-up, there were 506 incident CHD events, 311 IS events, 739 HF events, and 219 VTE events. There were no significant associations between self-reported history of ET and any of our outcomes (HR (95%CI): CHD = 1.16 (0.87,1.44), IS = 0.77 (0.55,1.09), HF = 1.00 (0.81,1.24), VTE = 0.98 (0.67,1.43)) after adjustment. Our results do not support an independent association between ET and development of CHD, IS, HF, or VTE.

Identifiants

pubmed: 31965569
doi: 10.1111/jphd.12353
pmc: PMC10243204
mid: NIHMS1898958
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-91

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201100012C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL59367
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100010C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059367
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011C
Pays : United States
Organisme : NIDCR NIH HHS
ID : DE 13807-01A1
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009I
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE011551
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005G
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100008I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007C
Pays : United States
Organisme : NIDCR NIH HHS
ID : DE1 1551
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007779
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100006C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005C
Pays : United States

Informations de copyright

© 2020 American Association of Public Health Dentistry.

Références

Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
J Endod. 2013 Oct;39(10):1205-17
pubmed: 24041380
Swed Dent J Suppl. 2007;(189):11-78, 1 p preceding table of contents
pubmed: 18047231
J Am Heart Assoc. 2016 Aug 30;5(9):
pubmed: 27577582
Ann Epidemiol. 2010 Aug;20(8):610-6
pubmed: 20609341
J Am Coll Cardiol. 2011 Apr 19;57(16):1690-6
pubmed: 21492767
Circulation. 2017 Jan 3;135(1):7-16
pubmed: 27831499
J Am Dent Assoc. 2009 Aug;140(8):1004-12
pubmed: 19654253
Stroke. 2016 Jun;47(6):1612-7
pubmed: 27165961
J Dent Res. 2003 Dec;82(12):998-1001
pubmed: 14630902
Stroke. 1999 Apr;30(4):736-43
pubmed: 10187871
Am J Med. 2004 Jul 1;117(1):19-25
pubmed: 15210384
Am J Cardiol. 2008 Apr 1;101(7):1016-22
pubmed: 18359324
J Dent Res. 2006 Nov;85(11):996-1000
pubmed: 17062738
J Endod. 2014 Feb;40(2):164-7
pubmed: 24461397
Acta Odontol Scand. 2003 Oct;61(5):257-62
pubmed: 14763775
J Endod. 2006 Feb;32(2):99-103
pubmed: 16427454
Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1816-22
pubmed: 11701471
J Periodontol. 2004 Jun;75(6):782-90
pubmed: 15295942
J Clin Epidemiol. 1996 Feb;49(2):223-33
pubmed: 8606324
J Public Health Dent. 2002 Spring;62(2):122-8
pubmed: 11989207
J Conserv Dent. 2010 Oct;13(4):233-9
pubmed: 21217951
J Endod. 2012 May;38(5):589-93
pubmed: 22515884
J Dent Res. 2016 Nov;95(12):1358-1365
pubmed: 27466397

Auteurs

Logan T Cowan (LT)

Department of Biostatistics, Epidemiology and Environmental Health Sciences, Georgia Southern University, Statesboro, GA, USA.

Kamakshi Lakshminarayan (K)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Pamela L Lutsey (PL)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

James Beck (J)

Department of Dental Ecology, School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.

Steven Offenbacher (S)

Department of Periodontology, School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.

James S Pankow (JS)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH